Cardiovascular disease (CVD) is the leading cause of death in patients with diabetes mellitus. Several hypoglycemic agents have undergone CV outcome trials (CVOTs) that focus on patients with pre-existing CVD or are at high risk of developing CVD. In this issue of Diabetes News Nucleus, let us learn more about the anti-diabetic drugs and CV outcomes.
Dr. Rajiv Kovil
Medical Director and Consultant Diabetologist,Dr. Kovils Diabetes Care Center,Mumbai
